Neuspera eyes FDA approval for urinary incontinence implant
The company’s urinary incontinence implant met the primary endpoint in the device trial, with Neuspera now looking to submit the data to the FDA.
Healthtech
Healthcare cybersecurity risk ‘higher than ever’ due to pandemic
Robots with skin: What is next for humanoids?
The tech trends in medical devices and the impact on timelines
Vitestro’s robotic blood drawing device meets trial endpoints
mHealth apps and healthcare access
“New frontier” for xenotransplantation as pig kidney patient leaves hospital
FemTech: the world’s largest ‘niche’ market
